Stock Analysts’ upgrades for Saturday, September 9th:

Automatic Data Processing (NYSE:ADP) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Advaxis (NASDAQ:ADXS) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Civeo Corporation (NYSE:CVEO) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

CVR Refining, (NYSE:CVRR) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Forest City Enterprises (NASDAQ:FCE-A) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Foundation Medicine (NASDAQ:FMI) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Inovio Pharmaceuticals (NASDAQ:INO) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Jernigan Capital (NYSE:JCAP) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Perrigo (NYSE:PRGO) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

Retail Properties of America (NYSE:RPAI) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Taro Pharmaceutical Industries (NYSE:TARO) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

VimpelCom (NASDAQ:VEON) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Wildhorse Resource Development Corporation (NYSE:WRD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “WildHorse Resource Development Corporation is an oil and natural gas company. It focused on the acquisition, exploration, development and production of oil, natural gas and NGL. The company properties primarily consist of Eagle Ford Shale in East Texas and the Over-Pressured Cotton Valley in North Louisiana. WildHorse Resource Development Corporation is based in Houston, Texas. “

W&T Offshore (NYSE:WTI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.25 target price on the stock. According to Zacks, “W&T Offshore is an independent oil and natural gas company focused primarily in the Gulf of Mexico area, including the deep water. They have grown through acquisition, exploitation and exploration. W&T has grown through acquisition, exploitation and exploration and now holds working interests in over two hundred fields in federal and state waters and a majority of its daily production is derived from wells it operates. “

Xenetic Biosciences (NASDAQ:XBIO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $3.00 target price on the stock. According to Zacks, “Xenetic Biosciences Inc. is a biopharmaceutical company. It develops biologic drugs, oncology therapeutics and vaccinations. The Company’s proprietary drug technology platforms include PolyXen (R) for the development of next generation biologic drugs and OncoHist (R) for the development of oncology drugs focused on orphan indications. Xenetic Biosciences Inc. based in United States. “

China Rapid Finance Limited Sponsored ADR (NYSE:XRF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “China Rapid Finance Limited provides investment management solutions and financial advisory services. It operates an integrated online platform which offers risk decision management system, marketing planning system, overdue debts collection system and accounting service system. China Rapid Finance Limited is headquartered in Shanghai, China. “

YY (NASDAQ:YY) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Zymeworks (NASDAQ:ZYME) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada. “

Receive News & Ratings for Automatic Data Processing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Automatic Data Processing and related companies with MarketBeat.com's FREE daily email newsletter.